Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Llorca

Showing results (41-50 of 166) with videos related to

Pageof 17
Sort By:
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|November 1, 1991
[Current hypotheses of the central mechanism of action of benzodiazepine tranquilizers]L P Bouchard, P M Llorca, M A Wolf
L'Encephale|July 1, 1996
[Clinical effects of clozapine: effect on negative symptoms]P M Llorca, C Lançon, P Auquier, et al.
L'Encephale|December 6, 2011
[The contributions of the evidence-based medicine or how to optimize the management of major depressive disorder]P-M Llorca, T Charpeaud, A Nourry, et al.
Acta Psychiatrica Scandinavica|September 24, 1999
Validity and reliability of the French-language version of the Positive and Negative Syndrome Scale (PANSS)C Lançon, G Reine, P M Llorca, et al.
L'Encephale|June 17, 2005
[The information of the schizophrenic patient: actuality]J Palazzolo, G Brousse, P Favre, et al.
Acta Psychiatrica Scandinavica|December 9, 1998
Factorial structure of the Positive and Negative Syndrome Scale (PANSS): a forced five-dimensional factor analysisC Lançon, V Aghababian, P M Llorca, et al.
L'Encephale|December 16, 2004
[Therapeutic adherence and schizophrenia: the interest of the validation of the French translation of Medication Adherence Rating Scale (MARS)]D Misdrahi, H Verdoux, P-M Llorca, et al.
International Journal of Clinical Practice|April 29, 2005
Efficacy of escitalopram in patients with severe depression: a pooled analysisP-M Llorca, J-M Azorin, N Despiegel, et al.
L'Encephale|September 1, 1993
[Comparative efficacy of bromocriptine, carbamazepine and cyproheptadine with neuroleptics in 24 refractory chronic schizophrenic patients]P M Llorca, M A Wolf, C Lançon, et al.
L'Encephale|July 2, 2002
[Compliance in schizophrenia: predictive factors, therapeutical considerations and research implications]D Misdrahi, P M Llorca, C Lançon, et al.
Pageof 17

Showing results (41-50 of 166) with videos related to

Sort By:
Pageof 17
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|November 1, 1991
[Current hypotheses of the central mechanism of action of benzodiazepine tranquilizers]L P Bouchard, P M Llorca, M A Wolf
L'Encephale|July 1, 1996
[Clinical effects of clozapine: effect on negative symptoms]P M Llorca, C Lançon, P Auquier, et al.
L'Encephale|December 6, 2011
[The contributions of the evidence-based medicine or how to optimize the management of major depressive disorder]P-M Llorca, T Charpeaud, A Nourry, et al.
Acta Psychiatrica Scandinavica|September 24, 1999
Validity and reliability of the French-language version of the Positive and Negative Syndrome Scale (PANSS)C Lançon, G Reine, P M Llorca, et al.
L'Encephale|June 17, 2005
[The information of the schizophrenic patient: actuality]J Palazzolo, G Brousse, P Favre, et al.
Acta Psychiatrica Scandinavica|December 9, 1998
Factorial structure of the Positive and Negative Syndrome Scale (PANSS): a forced five-dimensional factor analysisC Lançon, V Aghababian, P M Llorca, et al.
L'Encephale|December 16, 2004
[Therapeutic adherence and schizophrenia: the interest of the validation of the French translation of Medication Adherence Rating Scale (MARS)]D Misdrahi, H Verdoux, P-M Llorca, et al.
International Journal of Clinical Practice|April 29, 2005
Efficacy of escitalopram in patients with severe depression: a pooled analysisP-M Llorca, J-M Azorin, N Despiegel, et al.
L'Encephale|September 1, 1993
[Comparative efficacy of bromocriptine, carbamazepine and cyproheptadine with neuroleptics in 24 refractory chronic schizophrenic patients]P M Llorca, M A Wolf, C Lançon, et al.
L'Encephale|July 2, 2002
[Compliance in schizophrenia: predictive factors, therapeutical considerations and research implications]D Misdrahi, P M Llorca, C Lançon, et al.
Pageof 17